Liraglutide

FDA Approved: * December 23, 2024
Pharm Company: * HIKMA PHARMS
Category: Diabetes

Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management.[5][6] In diabetes it is a less preferred agent compared to metformin.[5][7] Its effects on long-term health outcomes like heart disease and life expectancy are unclear.[5][8] It is given by injection under the skin.[5] Com... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Liraglutide 6 mg/ml Subcutaneous Injection
NDC: 0143-9144
Labeler:
Hikma Pharmaceuticals USA Inc.
Saxenda 6 mg/ml Subcutaneous Injection, Solution
NDC: 0169-2800
Labeler:
Novo Nordisk
Liraglutide 6 mg/ml Subcutaneous Injection
NDC: 0480-3667
Labeler:
Teva Pharmaceuticals USA, Inc.
Liraglutide 18 mg/3ml Subcutaneous Injection, Solution
NDC: 14403-3400
Labeler:
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)

Related Brands

Drugs with the same active ingredients